KLP Kapitalforvaltning AS Makes New Investment in Core Scientific, Inc. (NASDAQ:CORZ)

featured-image

KLP Kapitalforvaltning AS purchased a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 37,500 shares of the company’s stock, valued at approximately $527,000. Several other large investors also [...]

KLP Kapitalforvaltning AS purchased a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 37,500 shares of the company’s stock, valued at approximately $527,000.

Several other large investors also recently made changes to their positions in CORZ. ORG Wealth Partners LLC grew its holdings in shares of Core Scientific by 0.3% during the fourth quarter.



ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock worth $126,262,000 after buying an additional 26,649 shares in the last quarter. Geode Capital Management LLC raised its holdings in Core Scientific by 26.7% during the third quarter.

Geode Capital Management LLC now owns 5,276,573 shares of the company’s stock worth $62,594,000 after acquiring an additional 1,113,285 shares in the last quarter. State Street Corp boosted its position in Core Scientific by 17.0% during the third quarter.

State Street Corp now owns 4,006,922 shares of the company’s stock valued at $47,522,000 after purchasing an additional 583,493 shares during the last quarter. Rush Island Management LP bought a new position in Core Scientific in the third quarter valued at approximately $32,221,000. Finally, Charles Schwab Investment Management Inc.

increased its position in shares of Core Scientific by 23.8% during the 4th quarter. Charles Schwab Investment Management Inc.

now owns 2,392,092 shares of the company’s stock worth $33,609,000 after purchasing an additional 459,630 shares during the last quarter. Insider Transactions at Core ScientificIn other Core Scientific news, Director Jordan Levy purchased 62,500 shares of the stock in a transaction on Thursday, March 6th. The shares were purchased at an average price of $8.

01 per share, with a total value of $500,625.00. Following the acquisition, the director now directly owns 306,887 shares in the company, valued at approximately $2,458,164.

87. The trade was a 25.57 % increase in their position.

The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Todd A. Becker sold 134,250 shares of the firm’s stock in a transaction dated Monday, March 3rd.

The shares were sold at an average price of $10.75, for a total value of $1,443,187.50.

Following the sale, the director now owns 195,687 shares in the company, valued at $2,103,635.25. The trade was a 40.

69 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 530,041 shares of company stock valued at $7,870,352 over the last three months.

Company insiders own 32.00% of the company’s stock. Wall Street Analysts Forecast GrowthSeveral equities research analysts have recently commented on CORZ shares.

Compass Point cut their price objective on Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a report on Tuesday, February 25th.

Craig Hallum began coverage on shares of Core Scientific in a report on Tuesday, January 21st. They set a “buy” rating and a $24.00 target price for the company.

Canaccord Genuity Group reiterated a “buy” rating and issued a $17.00 price target on shares of Core Scientific in a research note on Wednesday, March 12th. Keefe, Bruyette & Woods started coverage on shares of Core Scientific in a research report on Monday, January 27th.

They set an “outperform” rating and a $22.00 price objective for the company. Finally, HC Wainwright reiterated a “buy” rating and issued a $17.

00 price objective on shares of Core Scientific in a research note on Tuesday, March 11th. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $19.

07.Check Out Our Latest Stock Report on Core ScientificCore Scientific Stock PerformanceCORZ opened at $7.15 on Friday.

Core Scientific, Inc. has a fifty-two week low of $2.61 and a fifty-two week high of $18.

63. The firm has a 50-day moving average of $10.25 and a 200 day moving average of $13.

00. The firm has a market cap of $2.11 billion, a P/E ratio of -1.

32 and a beta of 6.80. Core Scientific (NASDAQ:CORZ – Get Free Report) last released its earnings results on Wednesday, February 26th.

The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.

09. The firm had revenue of $94.93 million during the quarter, compared to analysts’ expectations of $97.

07 million. Equities research analysts predict that Core Scientific, Inc. will post 0.

52 earnings per share for the current fiscal year. About Core Scientific (Free Report)Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting.

The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.Read MoreFive stocks we like better than Core ScientificDividend Capture Strategy: What You Need to KnowShares of RH Down Nearly 40%: Where Investors Can Turn To NowBest Stocks Under $10.

00 Tariffs, Spin-Out, and R2 Updates Are Positive Signs for RivianWhat is MarketRankTM? How to Use itCathie Wood Loads Up on Baidu—Is It the Right Time to Buy?.